Literature DB >> 12797972

Mycoplasma pneumoniae: a reduced-genome intracellular bacterial pathogen.

María A Meseguer1, Alberto Alvarez, María T Rejas, Carlos Sánchez, José C Pérez-Díaz, Fernando Baquero.   

Abstract

Mycoplasma pneumoniae has classically been considered an extracellular (or membrane-associated) organism. Nevertheless, the recently elucidated genomic structure of this pathogen strongly suggest that this organism may have been subjected to the process of reductive genetic evolution which is characteristic of intracellular bacteria. We studied the Mycoplasma pneumoniae RYC15989 strain, recovered from a pericardial biopsy sample from a patient with atypical pneumonia and acute pericarditis. The interaction of this strain with human hepatocytes Hep-G2 and mouse neuroblastoma N2-A cell lines was investigated. Confocal laser scanning microscopy and electronic microscopy evidence is presented of the intracellular location of fluorochrome-labelled Mycoplasma pneumoniae in cell lines infected with the organism in vitro. This finding provides preliminary evidence of cellular invasive capacity of Mycoplasma pneumoniae and casts some new light on the pathogenic potential of Mycoplasma pneumoniae in host infection.

Entities:  

Mesh:

Year:  2003        PMID: 12797972     DOI: 10.1016/s1567-1348(02)00151-x

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  19 in total

1.  Structure of CARDS toxin, a unique ADP-ribosylating and vacuolating cytotoxin from Mycoplasma pneumoniae.

Authors:  Argentina Becker; T R Kannan; Alexander B Taylor; Olga N Pakhomova; Yanfeng Zhang; Sudha R Somarajan; Ahmad Galaleldeen; Stephen P Holloway; Joel B Baseman; P John Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

2.  Evaluation of LBM415 (NVP PDF-713), a novel peptide deformylase inhibitor, for treatment of experimental Mycoplasma pneumoniae pneumonia.

Authors:  Monica Fonseca-Aten; Christine M Salvatore; Asunción Mejías; Ana M Ríos; Susana Chávez-Bueno; Kathy Katz; Ana M Gómez; George H McCracken; R Doug Hardy
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

3.  Metabolic network percolation quantifies biosynthetic capabilities across the human oral microbiome.

Authors:  David B Bernstein; Floyd E Dewhirst; Daniel Segrè
Journal:  Elife       Date:  2019-06-13       Impact factor: 8.140

4.  Mycoplasma pneumoniae: Innocent Bystander or a True Cause of Central Nervous System Disease?

Authors:  Ari Bitnun; Susan E Richardson
Journal:  Curr Infect Dis Rep       Date:  2010-07       Impact factor: 3.725

5.  Mycoplasma pneumoniae Compared to Streptococcus pneumoniae Avoids Induction of Proinflammatory Epithelial Cell Responses despite Robustly Inducing TLR2 Signaling.

Authors:  R C A de Groot; H Zhu; T Hoogenboezem; A C J M de Bruijn; E Eenjes; A E J 't Jong; A I Belo; S C Estevão; J J Bajramovic; R J Rottier; M Kool; A M C van Rossum; W W J Unger
Journal:  Infect Immun       Date:  2022-07-11       Impact factor: 3.609

Review 6.  New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections.

Authors:  Ken B Waites; Mitchell F Balish; T Prescott Atkinson
Journal:  Future Microbiol       Date:  2008-12       Impact factor: 3.165

Review 7.  Is asthma an infectious disease? New evidence.

Authors:  T Prescott Atkinson
Journal:  Curr Allergy Asthma Rep       Date:  2013-12       Impact factor: 4.806

8.  The GimA locus of extraintestinal pathogenic E. coli: does reductive evolution correlate with habitat and pathotype?

Authors:  Timo Homeier; Torsten Semmler; Lothar H Wieler; Christa Ewers
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

9.  Invasion of Ureaplasma diversum in Hep-2 cells.

Authors:  Lucas Miranda Marques; Priscilla M Ueno; Melissa Buzinhani; Beatriz A Cortez; Renata L Neto; Maurício Yamaguti; Rosângela C Oliveira; Ana Márcia S Guimarães; Telma A Monezi; Antonio Carlos R Braga; Gláucia M Machado-Santelli; Jorge Timenetsky
Journal:  BMC Microbiol       Date:  2010-03-17       Impact factor: 3.605

10.  Inhibition of message for FcepsilonRI alpha chain blocks mast cell IL-4 production induced by co-culture with Mycoplasma pneumoniae.

Authors:  Danlin Luo; Yuling Dai; Lynn B Duffy; T Prescott Atkinson
Journal:  Microb Pathog       Date:  2007-10-24       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.